Cellectis S.A. American Depositary Shares. Replay the stock market charts of CLLS day by day back to 2003. Open long and short positions without spending any money. Cellectis SA is a gene-editing company, employing its core proprietary technologies to develop products in the emerging field of immuno-oncology. Its two segment includes Therapeutics and Plants.
